The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2011
Filed:
Aug. 06, 2008
Stanley Dawes Chamberlain, Chapel Hill, NC (US);
Felix Deanda, Jr., Durham, NC (US);
Roseanne Gerding, Durham, NC (US);
Masaichi Hasegawa, Tsukuba, JP;
Kevin Kuntz, Durham, NC (US);
Huangshu Lei, Durham, NC (US);
Yasushi Miyazaki, Tsukuba, JP;
Naohiko Nishigaki, Tsukuba, JP;
Samarjit Patnaik, Durham, NC (US);
Aniko Redman, Durham, NC (US);
John Brad Shotwell, Durham, NC (US);
Kirk Stevens, Durham, NC (US);
Joseph Wilson, Durham, NC (US);
Bin Yang, Durham, NC (US);
Stanley Dawes Chamberlain, Chapel Hill, NC (US);
Felix Deanda, Jr., Durham, NC (US);
Roseanne Gerding, Durham, NC (US);
Masaichi Hasegawa, Tsukuba, JP;
Kevin Kuntz, Durham, NC (US);
Huangshu Lei, Durham, NC (US);
Yasushi Miyazaki, Tsukuba, JP;
Naohiko Nishigaki, Tsukuba, JP;
Samarjit Patnaik, Durham, NC (US);
Aniko Redman, Durham, NC (US);
John Brad Shotwell, Durham, NC (US);
Kirk Stevens, Durham, NC (US);
Joseph Wilson, Durham, NC (US);
Bin Yang, Durham, NC (US);
GlaxoSmithKline LLC, Philadelphia, PA (US);
Abstract
Novel pyrrolopyrimidines as shown in formula (I): and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.